Gelonghui September 26th, Tibet Cheezheng tibetan medicine (002287.SZ) announced the employee stock ownership plan for 2024. The funding sources of this employee stock ownership plan include the company's provision of long-term incentive fund, legal employee compensation, self-raised funds, or other methods permitted by laws and regulations. The total amount of funds for this employee stock ownership plan does not exceed 156 million yuan, of which the company's provision of long-term incentive fund does not exceed 144 million yuan. The company does not provide any form of financial support such as financing, guarantees, or loans to the holders. The employee stock ownership plan uses "shares" as the subscription unit, with each share priced at 1.00 yuan. Employees must subscribe to integer multiples of shares, and the upper limit of the number of shares for this employee stock ownership plan is 156 million shares.
Based on the closing price of the company's stock on September 26, 2024, at 20.24 yuan per share, the maximum number of target stocks that can be held through secondary market purchases in this employee stock ownership plan is approximately 7.7075 million shares, accounting for 1.45% of the company's existing total share capital. There is still uncertainty regarding the final purchase situation of the target stocks, and the actual number of shares held will depend on the actual execution.
